A device for detecting recent cannabis use accurately and without stigma
Advancement of a Point-of-Need (PoN) platform device for accurate and destigmatized detection of recent cannabis use
This study is working on a handy device that can quickly check if someone has used cannabis recently by testing their saliva, making it easier and more acceptable to do drug tests in places like jobs and healthcare.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ricovr Healthcare INC. NIH-funded |
| Lab location | 1 site (Princeton, United States) |
| Project ID | NIH-11237305 on NIH RePORTER |
What this research studies
This research focuses on developing a point-of-need device that can accurately measure recent cannabis use through saliva samples. The device utilizes advanced plasmonic fiber optic absorbance biosensor technology to provide quick and reliable results, helping to address public health concerns associated with cannabis use. By offering a user-friendly and automated workflow, the device aims to reduce the stigma often associated with drug testing, making it more acceptable in various settings such as workplaces and healthcare environments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who use cannabis and may be subject to testing in workplaces or healthcare settings.
Not a fit: Patients who do not use cannabis or are not involved in environments where cannabis use is monitored may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a reliable and stigma-free method for detecting recent cannabis use, improving safety and health outcomes.
How similar studies have performed: While there have been advancements in drug detection technologies, this specific approach using a point-of-need biosensor for cannabis detection is relatively novel.
Where this research is happening
Princeton, United States
- Ricovr Healthcare INC. — Princeton, United States (Active)
Researchers
- Principal investigator: Seimetz, Joseph — Ricovr Healthcare INC.
- Study coordinator: Seimetz, Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.